A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
Giraudet AL, Cassier PA, Iwao-Fukukawa C, Garin G, Badel JN, Kryza D, Chabaud S, Gilles-Afchain L, Clapisson G, Desuzinges C, Sarrut D, Halty A, Italiano A, Mori M, Tsunoda T, Katagiri T, Nakamura Y, Alberti L, Cropet C, Baconnier S, Berge-Montamat S, Pérol D, Blay JY.
Giraudet AL, et al. Among authors: badel jn.
BMC Cancer. 2018 Jun 8;18(1):646. doi: 10.1186/s12885-018-4544-x.
BMC Cancer. 2018.
PMID: 29884132
Free PMC article.
Clinical Trial.